// SECTOR INVESTOR DOSSIER
Investors in Pharmaceuticals
22 investors with active positions in Pharmaceuticals unicorns — combined exposure across this sector $219B in paper valuation.
Note: combined paper valuation reflects overlapping investor positions — individual investors hold stakes in the same companies.
Goldman Sachs
INVESTMENT BANK2 companies in sector · $21B
↑ 31% PORTFOLIO STRENGTH↓ 44% PORTFOLIO RISKMorgan Stanley
INVESTMENT BANK2 companies in sector · $21B
↑ 41% PORTFOLIO STRENGTH↓ 51% PORTFOLIO RISKFidelity Investments
VC FUND1 company in sector · $20B
↑ 37% PORTFOLIO STRENGTH↓ 59% PORTFOLIO RISKWellington Management
VC FUND1 company in sector · $20B
↑ 29.4% PORTFOLIO STRENGTH↓ 47.1% PORTFOLIO RISKViking Global Investors
VC FUND1 company in sector · $20B
↑ 22.2% PORTFOLIO STRENGTH↓ 33.3% PORTFOLIO RISKJ.P. Morgan
VC FUND1 company in sector · $20B
↑ 25% PORTFOLIO STRENGTH↓ 66.7% PORTFOLIO RISKFlagship Pioneering
VC FUND1 company in sector · $20B
RA Capital Management
VC FUND1 company in sector · $20B
AstraZeneca
VC FUND1 company in sector · $20B
SoftBank Vision Fund
VC FUND1 company in sector · $7B
↑ 5% PORTFOLIO STRENGTH↓ 53% PORTFOLIO RISKSecondary market transaction
VC FUND1 company in sector · $7B
↑ 20% PORTFOLIO STRENGTH↓ 40% PORTFOLIO RISKQVT Financial
VC FUND1 company in sector · $7B
Vivek Ramaswamy
VC FUND1 company in sector · $7B
JPMorgan Chase
INVESTMENT BANK1 company in sector · $1B
↑ 23% PORTFOLIO STRENGTH↓ 49% PORTFOLIO RISKHillhouse Capital
VC FUND1 company in sector · $1B
↑ 26.3% PORTFOLIO STRENGTH↓ 36.8% PORTFOLIO RISKTemasek Holdings
SOVEREIGN1 company in sector · $1B
↑ 15% PORTFOLIO STRENGTH↓ 54% PORTFOLIO RISKQiming Venture Partners
VC FUND1 company in sector · $1B
↑ 9.1% PORTFOLIO STRENGTH↓ 36.4% PORTFOLIO RISKFidelity International
VC FUND1 company in sector · $1B
OrbiMed
VC FUND1 company in sector · $1B
Vivo Capital
VC FUND1 company in sector · $1B
Lilly Asia Ventures
VC FUND1 company in sector · $1B
Capital Today
VC FUND1 company in sector · $1B